English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA multinational consortium including the University of Utah has been awarded a $246 million federal contract by USAID to improve infectious disease detection and monitoring across the globe.
Tag: disease modeling
Human pluripotent stem cell-derived kidney organoids: Current progress and challenges
Human pluripotent stem cell (hPSC)-derived kidney organoids share similarities with the fetal kidney. However, the current hPSC-derived kidney organoids have some limitations, including the inability to perform nephrogenesis and lack of a c
UCLA-led team finds a stem-cell derived mechanism that could lead to regenerative therapies for heart damage
A UCLA-led team has identified an essential internal control mechanism that can promote the maturation of human stem cell-derived heart muscle cells, possibly leading to new therapies for heart disease and cardiac damage.
Remoteness didn’t protect Amazonian Tsimané from COVID-19
Voluntary collective isolation alone was ineffective to mitigate the spread of COVID-19 into small-scale, remote Indigenous communities of the Tsimané in the Bolivian Amazon.
Parkinson’s Disease: Uncovering Why Nicotine May Be Protective (for Some)
Parkinson’s disease is caused by a combination of genetic and environmental factors, one curious example being that people who smoke appear to be less likely to develop Parkinson’s. This may be due to interactions between nicotine and genetic variations in…
LLNL joins Human Vaccines Project to accelerate vaccine development and understanding of immune response
Lawrence Livermore National Laboratory has joined the international Human Vaccines Project, bringing Lab expertise and computing resources to the consortium to aid development of a universal coronavirus vaccine and improve understanding of immune response.
Scientists model ‘true prevalence’ of COVID-19 throughout pandemic
Scientists have developed a statistical framework that incorporates key COVID-19 data to model the true prevalence of this disease in the U.S. Their approach projects that in the U.S. as many as 60% of COVID-19 cases went undetected as of March 7, 2021.